Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaron Beijing Co., Ltd. Class H ( (HK:3759) ) just unveiled an announcement.
Pharmaron Beijing Co., Ltd. has announced a final cash dividend of RMB 2 per 10 shares for the financial year ending December 31, 2024. The distribution is contingent upon approval at the upcoming AGM, with an expected payout by the end of August 2025, reflecting the company’s solid financial performance and commitment to shareholder returns.
More about Pharmaron Beijing Co., Ltd. Class H
Pharmaron Beijing Co., Ltd. operates in the pharmaceutical industry, focusing on providing drug research and development services. The company is known for its comprehensive offerings in drug discovery, development, and manufacturing, catering to a global market.
YTD Price Performance: 10.53%
Average Trading Volume: 839
Technical Sentiment Signal: Sell
Current Market Cap: €5.75B
For an in-depth examination of 3759 stock, go to TipRanks’ Stock Analysis page.